GLP-1 receptor agonists. semaglutide, tirzepatide, and their growing roster of competitors. have moved from niche clinical tools to mainstream weight-management drugs in under three years. That shift is landing directly on gym floors, and operators who haven't updated their playbook are already feeling it in their 90-day retention numbers.
The core problem isn't that GLP-1 users don't want to exercise. It's that they arrive at your facility with a fundamentally different physiological profile than the members your programming was designed for. And if your staff can't meet them where they are, you'll lose them before they ever form a habit.
Who's Actually Walking Through Your Doors Now
GLP-1 users entering gyms typically present with accelerated fat loss but significant lean mass reduction alongside it. Studies tracking semaglutide users show that roughly 25 to 40 percent of total weight lost can come from muscle tissue, particularly in users who aren't following structured resistance training protocols. That's the member you're now acquiring. lighter on the scale, but weaker, more fatigued, and potentially undernourished relative to their training load.
This creates an immediate mismatch with traditional new-member programming. A high-intensity bootcamp designed to torch calories is not the right entry point for someone eating 1,200 calories a day, managing nausea, and dealing with reduced energy output. It's also not the environment that makes this person feel competent enough to come back.
What they actually need is structured resistance training, protein-focused nutrition coaching, and clear performance markers that have nothing to do with the scale. That's a significant departure from the weight-loss messaging most facilities still lean on during the January and September intake cycles.
The Muscle-Preservation Pivot Is Improving Retention
Franchises that have reoriented their onboarding around muscle-preservation goals, rather than calorie-burn outcomes, are reporting measurable improvements in 90-day retention. The logic is straightforward. When a GLP-1 user's primary outcome metric is weight, they hit a plateau or slowdown and disengage. When the metric shifts to grip strength, squat depth, or lean mass measured by DEXA or bioimpedance, there's always a direction to move in.
This is where programming specificity matters enormously. The ACSM's updated resistance training guidelines now explicitly address populations on weight-loss medications, recommending higher frequency resistance sessions and progressive overload protocols that protect lean mass during rapid fat loss phases. If your trainers aren't familiar with these updates, that's a staff development gap that's actively costing you retention.
Multi-location operators are also discovering that the tempo and structure of strength work matters as much as the exercises themselves. Slowing down the eccentric phase of movements, for example, produces significantly more mechanical tension per rep. a critical advantage for someone training in a caloric deficit. Skipping proper eccentric training in this population isn't just a programming gap, it's leaving measurable results on the table.
Acquisition Is Getting a New Pipeline
GLP-1 adoption is also creating new member acquisition channels that didn't exist two years ago. Partnerships between gyms and prescribing clinics or telehealth platforms are emerging as a genuine referral pipeline, with some operators reporting that clinic-referred members have higher initial intent and better 60-day attendance than standard new-member cohorts.
The investment signals are aligning with this trend. Altro Health's $7 million raise, structured around trainer-led GLP-1 referral pipelines, reflects growing institutional confidence that the intersection of fitness and weight-loss pharmacology is a durable revenue opportunity rather than a short-term trend. For gym operators, the implication is clear. the referring trainer or facility becomes a trusted partner in a member's medical journey, which creates a loyalty dynamic that's significantly harder to disrupt than a standard membership.
If you're evaluating this model, the first step is making sure your trainers are equipped to have informed conversations about GLP-1 use. That starts at intake. Understanding what a trainer should cover before session one gives you a framework for building intake protocols that identify GLP-1 users early and route them into appropriate programming tracks rather than the standard new-member funnel.
This is also worth watching in the context of broader premium gym investment. TDR Capital's $2.8 billion David Lloyd position reflects a broader thesis that premium, service-dense gym operators are structurally better positioned than budget players. GLP-1 integration is becoming part of what "service-dense" means in 2025 and beyond.
Community Programming Is Replacing Calorie-Burn Classes as the Primary Retention Tool
High-intensity group formats built around calorie expenditure are losing their grip on this cohort. GLP-1 users often struggle with fatigue, appetite suppression, and reduced tolerance for high-output sessions, particularly in the first 8 to 12 weeks of medication use. Stacking them into a 45-minute HIIT class and expecting retention is a structural mismatch.
What's replacing it. slower-paced, skill-based programming with an explicit social component. Strength fundamentals classes. Functional movement workshops. Small-group coaching sessions built around measurable performance goals. These formats do two things simultaneously: they deliver an appropriate physiological stimulus and they create community attachment, which is consistently the strongest predictor of long-term gym retention across every demographic studied.
The upsell economics here are significant. Personalized coaching. either one-on-one sessions or small-group coaching packages. is now the highest-margin product in the facilities successfully serving this population. At $80 to $150 per session in most US markets, or $300 to $600 per month for small-group packages, coaching revenue can materially shift a facility's revenue per member without requiring new square footage or significant capital investment.
This also connects to a broader content and programming philosophy. Members who understand the science behind their training stay longer. Building programming that explains why eccentric loading matters, why protein timing is different when appetite is pharmacologically suppressed, or why exercise variety protects long-term adherence turns every coaching touchpoint into an education moment that deepens loyalty.
The 60-Day Window Is Where You Win or Lose This Cohort
GLP-1 users are more vulnerable to early dropout than the average new member, and the reasons are specific. Fatigue from caloric restriction and medication adjustment peaks in weeks two through six. Muscle soreness from resistance training, which may feel more acute in a depleted state, creates a negative association with the gym experience if not properly managed. Reduced appetite means post-workout nutrition habits that work for other members simply don't apply.
Operators who haven't trained front-of-house and coaching staff on these side effects are essentially flying blind during the most critical retention window. The first 60 days are your most concentrated retention opportunity, and for GLP-1 users, the interventions need to be more proactive and more personalized than your standard check-in protocol delivers.
Practical staff training should cover at minimum: recognizing signs of overtraining in calorie-restricted members, knowing when to adjust session intensity without the member feeling like they've failed, and understanding basic protein requirements for muscle preservation in GLP-1 users. Research suggests that protein intake of 1.2 to 1.6 grams per kilogram of body weight is essential for preserving lean mass during rapid weight loss. that's a number your trainers should be able to reference confidently.
Medical fitness competitors, including hospital-affiliated wellness programs and physician-supervised fitness centers, are actively targeting this same population. They're marketing clinical expertise as the differentiator. If your staff can't demonstrate equivalent fluency in the physiology of GLP-1 use, you're competing on price alone, which is not a position any premium or mid-market operator wants to be in.
What Forward-Looking Operators Are Actually Doing
The facilities gaining traction with GLP-1 users share a few common structural features. They've updated their intake questionnaires to capture medication use and flag it for programming customization. They've built dedicated onboarding tracks, typically 4 to 8 week progressions, specifically designed for members in rapid weight-loss phases. And they've trained at least a subset of their coaching staff to hold informed conversations about muscle preservation, protein strategy, and realistic performance timelines.
They're also thinking about programming diversity more deliberately. The evidence on how different training modalities contribute to lean mass maintenance during caloric restriction is nuanced, and your coaches need to understand those nuances. Whether the conversation is about resistance equipment, bodyweight alternatives, or how to structure sessions for a member with significantly reduced energy availability, programming flexibility is now a core competency rather than a nice-to-have.
The operators who treat GLP-1 adoption as a temporary trend to weather will find themselves outpaced by those treating it as a structural shift in member needs. The drug category isn't going away. Goldman Sachs projects the global GLP-1 market to exceed $100 billion by 2030. The members are already here. The question is whether your business model is built to serve them.